INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Semi loses load on I-70 WB ramp to I-65N split
A tractor-trailer lost its load early Friday on Interstate 70 west near the North Split to I-65.
State employee quits job over RFRA
A state employee quit his job Thursday in response to Gov. Mike Pence signing the Religious Freedom Restoration Act.
Woman killed, man injured in east-side shooting
A woman was killed and a man was injured in a drug-related shooting on the city’s east side Thursday evening.
Milwaukee Bucks beat Pacers 111-107
MILWAUKEE (AP) — Ersan Ilyasova had a career-high 34 points and the Milwaukee Bucks held off the Indiana Pacers 111-107 on Thursday night.
Three injured in multi-car crash on west side
Three females were injured in a multi-vehicle crash on the city’s west side Thursday afternoon.